NasdaqGM - Nasdaq Real Time Price USD

AtriCure, Inc. (ATRC)

22.61 -0.44 (-1.91%)
At close: April 25 at 4:00 PM EDT
22.65 +0.04 (+0.18%)
After hours: April 25 at 4:35 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
399,245.00
399,245.00
330,379.00
274,329.00
206,531.00
Cost of Revenue
98,875.00
98,875.00
84,439.00
68,469.00
57,222.00
Gross Profit
300,370.00
300,370.00
245,940.00
205,860.00
149,309.00
Operating Expense
327,053.00
327,053.00
288,609.00
253,155.00
193,899.00
Operating Income
-26,683.00
-26,683.00
-42,669.00
-47,295.00
-44,590.00
Net Non Operating Interest Income Expense
-3,133.00
-3,133.00
-2,992.00
-4,452.00
-3,784.00
Other Income Expense
-31.00
-31.00
-537.00
102,134.00
333.00
Pretax Income
-29,847.00
-29,847.00
-46,198.00
50,387.00
-48,041.00
Tax Provision
591.00
591.00
268.00
188.00
114.00
Net Income Common Stockholders
-30,438.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Diluted NI Available to Com Stockholders
-30,438.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Basic EPS
-0.66
--
-1.02
1.11
-1.14
Diluted EPS
-0.66
--
-1.02
1.09
-1.14
Basic Average Shares
46,309.00
--
45,740.00
45,066.00
42,125.00
Diluted Average Shares
46,309.00
--
45,740.00
46,039.00
42,125.00
Total Operating Income as Reported
-26,683.00
-26,683.00
-42,669.00
55,205.00
-44,233.00
Total Expenses
425,928.00
425,928.00
373,048.00
321,624.00
251,121.00
Net Income from Continuing & Discontinued Operation
-30,438.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Normalized Income
-30,438.00
-30,438.00
-46,466.00
-51,891.00
-48,415.61
Interest Income
3,792.00
3,792.00
1,994.00
466.00
1,101.00
Interest Expense
6,925.00
6,925.00
4,986.00
4,918.00
4,885.00
Net Interest Income
-3,133.00
-3,133.00
-2,992.00
-4,452.00
-3,784.00
EBIT
-22,922.00
-22,922.00
-41,212.00
55,305.00
-43,156.00
EBITDA
-8,109.00
-8,109.00
-29,502.00
65,746.00
-33,608.00
Reconciled Cost of Revenue
98,875.00
98,875.00
84,439.00
68,469.00
57,222.00
Reconciled Depreciation
14,813.00
14,813.00
11,710.00
10,441.00
9,548.00
Net Income from Continuing Operation Net Minority Interest
-30,438.00
-30,438.00
-46,466.00
50,199.00
-48,155.00
Total Unusual Items Excluding Goodwill
--
--
--
102,500.00
357.00
Total Unusual Items
--
--
--
102,500.00
357.00
Normalized EBITDA
-8,109.00
-8,109.00
-29,502.00
-36,754.00
-33,965.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
410.00
96.39
12/31/2020 - 8/5/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANGO AngioDynamics, Inc.
5.78
-1.53%
 
STVN Stevanato Group S.p.A.
27.52
+0.77%
 
HAE Haemonetics Corporation
87.66
+1.67%
 
BLFS BioLife Solutions, Inc.
16.86
-1.92%
 
EMBC Embecta Corp.
10.40
-4.50%
 
MMSI Merit Medical Systems, Inc.
73.38
-0.88%
 
LMAT LeMaitre Vascular, Inc.
62.99
-1.62%
 
ICUI ICU Medical, Inc.
94.53
-2.26%
 
UTMD Utah Medical Products, Inc.
66.29
-1.30%
 
AZTA Azenta, Inc.
51.50
-1.13%